The global metastatic castration-sensitive prostate cancer treatment market is showing significant expansion. This boom can be linked to factors such as an elevating population, rising prevalence of prostate cancer, and advancements in treatment methods. The market is further driven by enhanced awareness about the disease and its therapy options… Read More